A 52-year-old woman from rural Maharashtra presents with progressive dyspnea, palpitations, and a diastolic murmur at the apex. Echocardiography confirms severe mitral stenosis with atrial fibrillation. Regarding the complications and management of mitral stenosis, all of the following are true EXCEPT:

Question

Accepted Answer

D. Surgical commissurotomy or valve replacement is indicated when the mitral valve area falls below 1.0 cm² or symptoms persist despite medical therapy. ## Management and Complications of Mitral Stenosis

**Key Point:** The threshold for intervention in mitral stenosis is a mitral valve area of **≤1.5 cm²** (moderate-to-severe stenosis), NOT 1.0 cm². Intervention is considered when the valve area falls below this threshold AND symptoms are present or the patient is at high risk of complications.

### Mitral Valve Area Classification

| Severity | Valve Area (cm²) | Hemodynamics |
| --- | --- | --- |
| **Normal** | >4.0 | No obstruction |
| **Mild** | 2.5–4.0 | Minimal gradient |
| **Moderate** | 1.5–2.5 | Moderate gradient, symptoms with exertion |
| **Severe** | <1.5 | High gradient, symptoms at rest, pulmonary HTN |
| **Critical** | <1.0 | Severe hemodynamic compromise |

**High-Yield:** Intervention (percutaneous mitral commissurotomy or surgical valve replacement) is indicated when:
1. Mitral valve area **≤1.5 cm²** AND
2. Symptoms present (dyspnea, orthopnea, palpitations) OR
3. Complications develop (pulmonary edema, atrial fibrillation, thromboembolism)

A valve area of 1.0 cm² represents **critical stenosis** — by this point, intervention is already urgently needed. The cutoff for decision-making is 1.5 cm², not 1.0 cm².

### Why Option 2 is Wrong

The statement conflates two concepts:
- **Valve area ≤1.0 cm²** = critical stenosis (already severe, intervention overdue)
- **Decision threshold ≤1.5 cm²** = moderate-to-severe stenosis (when intervention is first considered)

Using 1.0 cm² as the threshold would delay intervention in symptomatic patients with valve areas of 1.0–1.5 cm², exposing them to unnecessary risk of acute pulmonary edema, stroke, or hemodynamic collapse.

### Correct Features (Options 0, 1, 3)

**Option 0 (Correct):** Atrial fibrillation in mitral stenosis creates a low-flow state in the enlarged left atrium → thrombus formation → systemic embolism (especially stroke). Anticoagulation with warfarin (or DOAC if suitable) is standard of care.

**Option 1 (Correct):** Acute pulmonary edema in mitral stenosis is managed by:
- **Diuretics** (reduce pulmonary congestion)
- **Nitrates** (reduce preload and afterload)
- **Beta-blockers or calcium-channel blockers** (slow ventricular rate in AF, reduce cardiac output demand, allow longer diastolic filling time)
- Avoid positive inotropes (increase heart rate and worsen obstruction)

**Option 3 (Correct):** Aortic regurgitation (AR) is a frequent associated lesion in rheumatic mitral stenosis. The combination of MS + AR indicates more extensive rheumatic valve damage and is associated with worse prognosis and earlier need for intervention.

**Clinical Pearl:** In a patient with mitral stenosis and new-onset atrial fibrillation, the priority is rate control (slow the ventricular rate to allow longer diastolic filling across the stenotic valve) and anticoagulation to prevent stroke.

[cite:Harrison 21e Ch 297; Robbins 10e Ch 12]

Answer

A. Anticoagulation with warfarin is indicated because of the high risk of systemic thromboembolism from the fibrillating left atrium

Answer

B. Aortic regurgitation is a common associated lesion in rheumatic mitral stenosis and indicates more severe rheumatic heart disease

Answer

C. Acute pulmonary edema in mitral stenosis is best managed with diuretics, nitrates, and beta-blockers to slow the ventricular rate

Explanation

Management and Complications of Mitral Stenosis

Mitral Valve Area Classification

Why Option 2 is Wrong

Correct Features (Options 0, 1, 3)

Practice similar questions

Join our NEET PG community

Severity	Valve Area (cm²)	Hemodynamics
Normal	>4.0	No obstruction
Mild	2.5–4.0	Minimal gradient
Moderate	1.5–2.5	Moderate gradient, symptoms with exertion
Severe	<1.5	High gradient, symptoms at rest, pulmonary HTN
Critical	<1.0	Severe hemodynamic compromise